Table 1 Summary of M. tuberculosis susceptibility profile test based on Genotype MTBDRplus compared to gender, HIV co-infection and previous use of first line drugs against tuberculosis
Gender | HIV | Previous treatment of TB | Total | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
M. tb status | M | F | Unk | p value | Pos | Neg | Unk | p value | Yes | No | Unk | p value | |
Susceptible | 55 71.4 % | 49 79.0 % | 11 (68.7) | 0,33 | 29 66.0 % | 20 71.4 % | 66 79.6 % | 0,80 | 73 72.2 % | 33 80.5 % | 9 69.2 % | 0,02 | 115 74.2 % |
MDR-TB | 12 15.6 % | 10 16.2 % | 3 (18.8) | 11 25.0 % | 5 17.9 % | 9 (10.8) | 20 19.8 % | 4 9.8 % | 1 7.7 % | 25 16.1 % | |||
R-mono resistant | 2 2.6 % | 0 | 0 (0.0) | 1 2.2 % | 0 | 1 1.2 % | 1 1.0 % | 1 2.4 % | 0 | 2 1.3 % | |||
H-mono resistant | 8 10.4 % | 3 4.8 % | 2 (12.5) | 3 6.8 % | 3 10.7 % | 7 8.4 % | 7 7.0 % | 3 7.3 % | 3 23.1 % | 13 8.4 % | |||
Total | 77 | 62 | 16 | 44 | 28 | 83 | 101 | 41 | 13 | 155 100 % | |||